Candida albicans 菌株拉丁名
(Robin) Berkhout
(ATCC® 2091™) 菌株編號(hào)
Permits and Restrictions View Permits
Deposited As Endomyces albicans (Robin) Vuillemin
Strain Designations 菌株別名 132 [CBS 2730, CIP 1180.79, IFO 1393, NCYC 854]
Application Pharmaceutical and Personal Care
Biosafety Level 生物安全等級(jí) 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Storage Conditions Frozen 保藏方法 : -80℃ or colder
Freeze-Dried 凍干物 : 2℃ to 8℃
Live Culture 活菌 : See Propagation Section
Type Strain 模式菌株 no
Antigenic Properties Serotype A Ref
Preceptrol® no
Morphology Colonies after 3 days cream-colored, dull, often becoming wrinkled with a mycelial border on prolonged incubation.
Yeast cells globose to short-ovoid, hyaline, 2-7 x 3-8.5 µm, single or budding, occasionally forming short chains.
Medium 培養(yǎng)基 ATCC® Medium 28: Emmons' modification of Sabouraud's agar
ATCC® Medium 200: YM agar or YM broth
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 28℃
Atmosphere 需氧情況 : Typical aerobic
Name of Depositor R Chodat
Cross References Nucleotide (GenBank) : KU729048 ITS including 5.8S rRNA gene
References 參考文獻(xiàn) Morrison CJ, et al.
Heterogeneity of the purified extracellular aspartyl proteinase from Candida albicans:
characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect. Immun. 61: 2030-2036, 1993. PubMed: 8478090
British Pharmacopoeia Commission Test for sterility. London, UK:British Pharmacopoeia Commission;
British Pharmacopoeia Appendix XVI A, 2003 British Pharmacopoeia Commission Tests for microbial contamination.
London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XVI B, 2003
Wagner T, et al. pH-dependent denaturation of extracellular aspartic proteinases from Candida species. J. Med. Vet. Mycol. 33: 275-278, 1995. PubMed: 8531028
Morrison CJ, et al. Purification and characterization of the extracellular aspartyl proteinase of Candida albicans: removal of extraneous proteins and cell wall mannoprotein and evidence for lack of glycosylation. J. Gen. Microbiol. 139: 1177-1186, 1993. PubMed: 8360611
European Pharmacopoeia Commission Sterility. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.6.1, 1997
European Pharmacopoeia Commission Microbial contamination of products not required to comply with the test for sterility (total viable aerobic count).
Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.6.12, 1997
Microbial limit test. Tokyo, Japan:Japanese Pharmacopoeia;JP Jp14e.part I.35. Microbial limit test for crude drugs. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.36.
U.S. Pharmacopeia General Chapters: <1072> Disinfectants and Antiseptics. Rockville, MD. USP34-NF29, 2011 ISO/CD 11133:2009,
Annex E. Test microorganisms for commonly used culture media (giving information on the culture medium, culture conditions, test microorganisms, culture collection number of test organisms and the expected reactions) Corry, JEL, Curtis, GDW and Baird, RM (Eds) Handbook of Culture Media for Food and Water Microbiology.
Royal Society of Chemistry, In preparation. ICFMH-WPCM. Wagner T, et al. pH-dependent denaturation of extracellular aspartic proteinases from Candida species. J. Med. Vet. Mycol. 33: 275-278, 1995. PubMed: 8531028
